Raloxifene in Hemodialysis Patients

Author Information
Article Notes and Dates
To Cite : Keller F. Raloxifene in Hemodialysis Patients, Int J Endocrinol Metab. 2012 ;10(3):576-576. doi: 10.5812/ijem.5457.
Copyright: Copyright © 2012, International Journal of Endocrinology and Metabolism. .
Footnotes
References
  • 1. Saito O, Saito T, Asakura S, Akimoto T, Inoue M, Ando S, et al. Effects of raloxifene on bone metabolism in hemodialysis patients with type 2 diabetes. Int J Endocrinol Metab. 2012; 10: 464-9[DOI]
  • 2. Czock D, Keller F, Heringa M, Rasche FM. Raloxifene pharmacokinetics in males with normal and impaired renal function. Br J Clin Pharmacol. 2005; 59(4): 479-82[DOI][PubMed]
  • 3. Ishani A, Blackwell T, Jamal SA, Cummings SR, Ensrud KE. The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol. 2008; 19(7): 1430-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check